FOR IMMEDIATE RELEASE
April 13, 2023
Contact: Sarah Shelson
WASHINGTON — Patients Rising Now CEO and Co-founder Terry Wilcox today released the following statement regarding MedPAC’s recommendation to modify reimbursements for Medicare Part B medicines that have gone through accelerated approval:
“The accelerated approval process is a lifeline to patients with severe illnesses who are in a race against the clock with their disease and have no treatments and no hope. This recommendation from MedPAC will severely limit the ability of patients with rare and chronic diseases to access the care they depend on.
It also undermines the FDA’s authority over drug approval processes. Let’s not forget, accelerated approval is approval, and these attacks on the pipeline will jeopardize patient access to current and future life-saving treatments.”